Literature DB >> 2837655

Stably transmitted triple-promoter retroviral vectors and their use in transformation of primary mammalian cells.

R W Overell1, K E Weisser, D Cosman.   

Abstract

Retroviral vectors were constructed which coexpressed three inserted genes from independent transcriptional promoters in singly infected cells. Several such triple-promoter vectors were constructed with various combinations of oncogenes and selectable drug resistance genes. All expressed three mRNAs of the expected size in infected cells. One vector expressing the v-Ha-ras, v-myc, and neo genes was characterized in detail. This retrovirus did not undergo rearrangement during the process of infection, as judged by Southern analysis, and infection of primary rat embryo fibroblasts demonstrated that ras-myc-cotransformed cells could be selected in G418. This demonstration that retroviral vectors can be used to express three cistrons independently increases their value as gene transfer vehicles, particularly for studies involving oncogene cooperation in primary cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837655      PMCID: PMC363342          DOI: 10.1128/mcb.8.4.1803-1808.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40.

Authors:  S A Aaronson; G J Todaro
Journal:  J Cell Physiol       Date:  1968-10       Impact factor: 6.384

2.  Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus.

Authors:  K Shimotohno; H M Temin
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

3.  Molecular cloning of the avian myelocytomatosis virus genome and recovery of infectious virus by transfection of chicken cells.

Authors:  B Vennström; C Moscovici; H M Goodman; J M Bishop
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

4.  The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.

Authors:  R W Ellis; D Defeo; T Y Shih; M A Gonda; H A Young; N Tsuchida; D R Lowy; E M Scolnick
Journal:  Nature       Date:  1981-08-06       Impact factor: 49.962

5.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

6.  Transcriptional control signals of a eukaryotic protein-coding gene.

Authors:  S L McKnight; R Kingsbury
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

7.  Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells.

Authors:  C M Corsaro; M L Pearson
Journal:  Somatic Cell Genet       Date:  1981-09

8.  Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene.

Authors:  R F Newbold; R W Overell
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

9.  Molecular cloning and characterization of avian sarcoma virus circular DNA molecules.

Authors:  W J DeLorbe; P A Luciw; H M Goodman; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

10.  Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.

Authors:  U R Rapp; M D Goldsborough; G E Mark; T I Bonner; J Groffen; F H Reynolds; J R Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

View more
  13 in total

1.  Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene.

Authors:  S D Lupton; L L Brunton; V A Kalberg; R W Overell
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

Review 2.  Retroviral vectors. From laboratory tools to molecular medicine.

Authors:  R G Vile; A Tuszynski; S Castleden
Journal:  Mol Biotechnol       Date:  1996-04       Impact factor: 2.695

3.  Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy.

Authors:  P M Cannon; N Kim; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Recombinant retrovirus vectors for the expression of MHC class II heterodimers.

Authors:  H Shimada; R C Alexander; S Germana; D H Sachs; C LeGuern
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Appropriate in vivo expression of a muscle-specific promoter by using avian retroviral vectors for gene transfer [corrected].

Authors:  C J Petropoulos; W Payne; D W Salter; S H Hughes
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

6.  The Francisella O-antigen mediates survival in the macrophage cytosol via autophagy avoidance.

Authors:  Elizabeth Di Russo Case; Audrey Chong; Tara D Wehrly; Bryan Hansen; Robert Child; Seungmin Hwang; Herbert W Virgin; Jean Celli
Journal:  Cell Microbiol       Date:  2013-12-16       Impact factor: 3.715

7.  Development of a retroviral vector for inducible expression of transforming growth factor beta 1.

Authors:  M L McGeady; P M Arthur; M Seidman
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos.

Authors:  I R Ghattas; J R Sanes; J E Majors
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

9.  Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex.

Authors:  L S Park; U Martin; R Sorensen; S Luhr; P J Morrissey; D Cosman; A Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

10.  Improvement of avian leukosis virus (ALV)-based retrovirus vectors by using different cis-acting sequences from ALVs.

Authors:  F L Cosset; C Legras; J L Thomas; R M Molina; Y Chebloune; C Faure; V M Nigon; G Verdier
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.